Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function

Clinical Science

Volumn 130, Issue 4, 2016, Pages 259-271

  Landoni, Veronica I ^a   Martire Greco, Daiana ^a   Rodriguez Rodrigues, Nahuel ^a   Chiarella, Paula ^a   Schierloh, Pablo ^a   Isturiz, Martin A ^a   Fernández, Gabriela C ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Bone marrow; Immunosuppression; Lipopolysaccharide; MDSC; Mice; Sepsis

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR7; REACTIVE OXYGEN METABOLITE; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE, ESCHERICHIA COLI 0111 B4; LY ANTIGEN; LY6G ANTIGEN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL CONTACT; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SELF-RENEWAL; CHEMOTAXIS; COCULTURE; CONTROLLED STUDY; HEMATOPOIESIS; IMMUNOSUPPRESSIVE TREATMENT; INOCULATION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SUPPRESSOR CELL; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; CELL CULTURE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SEPSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; BONE MARROW CELLS; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; CHEMOTAXIS; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; IMMUNOCOMPROMISED HOST; LIPOPOLYSACCHARIDES; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE, INBRED BALB C; MYELOID CELLS; REACTIVE OXYGEN SPECIES; SEPSIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84958046213     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150653     Document Type: Article

References (54)

1. Angus, D.C. and Van Der, Poll, T. (2013) Severe sepsis and septic shock. N. Engl. J. Med. 369, 2063
2. Kumar, G., Kumar, N., Taneja, A., Kaleekal, T., Tarima, S., McGinley, E., Jimenez, E., Mohan, A., Khan, R.A., Whittle, J. et al. (2011) Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 140, 1223-1231
3. Talmadge, J.E. (2007) Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin. Cancer Res. 13, 5243-5248
4. Stearns-Kurosawa, D.J., Osuchowski, M.F., Valentine, C., Kurosawa, S. and Remick, D.G. (2011) The pathogenesis of sepsis. Annu. Rev. Pathol. 6, 19-48
5. Munford, R.S. and Pugin, J. (2001) Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am. J. Respir. Crit. Care Med. 163, 316-321
6. Hotchkiss, R.S., Monneret, G. and Payen, D. (2013) Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862-874
7. Otto, G.P., Sossdorf, M., Claus, R.A., Rodel, J., Menge, K., Reinhart, K., Bauer, M. and Riedemann, N.C. (2011) The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care 15, R183
8. Osuchowski, M.F., Welch, K., Siddiqui, J. and Remick, D.G. (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177, 1967-1974
9. Adib-Conquy, M. and Cavaillon, J.M. (2009) Compensatory anti-inflammatory response syndrome. Thromb. Haemost. 101, 36-47
10. Cavaillon, J.M., Adrie, C., Fitting, C. and Adib-Conquy, M. (2003) Endotoxin tolerance: is there a clinical relevance? J. Endotoxin Res 9, 101-107
11. Benjamim, C.F., Hogaboam, C.M. and Kunkel, S.L. (2004) The chronic consequences of severe sepsis. J. Leukoc. Biol. 75, 408-412
12. West, M.A. and Heagy, W. (2002) Endotoxin tolerance: A review. Crit. Care Med. 30, S64-S73
13. Cavaillon, J.M. and Adib-Conquy, M. (2006) Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 10, 233
14. Rearte, B., Maglioco, A., Balboa, L., Bruzzo, J., Landoni, V.I., Laborde, E.A., Chiarella, P., Ruggiero, R.A., Fernandez, G.C. and Isturiz, M.A. (2010) Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice. Clin. Exp. Immunol. 162, 568-577
15. Martire-Greco, D., Landoni, V.I., Chiarella, P., Rodriguez-Rodrigues, N., Schierloh, P., Rearte, B., Isturiz, M.A. and Fernandez, G.C. (2014) All-trans-retinoic acid improves immunocompetence in a murine model of lipopolysaccharide-induced immunosuppression. Clin. Sci. (Lond.) 126, 355-365
16. Gabrilovich, D.I., Ostrand-Rosenberg, S. and Bronte, V. (2012) Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253-268
17. Gabrilovich, D.I. and Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174
18. Munera, V., Popovic, P.J., Bryk, J., Pribis, J., Caba, D., Matta, B.M., Zenati, M. and Ochoa, J.B. (2010) Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann. Surg. 251, 120-126
19. Bunt, S.K., Sinha, P., Clements, V.K., Leips, J. and Ostrand-Rosenberg, S. (2006) Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 176, 284-290
20. Noel, G., Wang, Q., Schwemberger, S., Hanson, C., Giacalone, N., Haar, L. and Ogle, C.K. (2011) Neutrophils, not monocyte/macrophages, are the major splenic source of postburn IL-10. Shock 36, 149-155
21. Cripps, J.G. and Gorham, J.D. (2011) MDSC in autoimmunity. Int. Immunopharmacol. 11, 789-793
22. Van Rompaey, N. and Le Moine, A. (2011) Myeloid-derived suppressor cells: characterization and expansion in models of endotoxemia and transplantation. Methods Mol. Biol. 677, 169-180
23. Derive, M., Bouazza, Y., Alauzet, C. and Gibot, S. (2012) Myeloid-derived suppressor cells control microbial sepsis. Intensive Care Med. 38, 1040-1049
24. Janols, H., Bergenfelz, C., Allaoui, R., Larsson, A.M., Ryden, L., Bjornsson, S., Janciauskiene, S., Wullt, M., Bredberg, A. and Leandersson, K. (2014) A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J. Leukoc. Biol. 96, 685-693
25. Darcy, C.J., Minigo, G., Piera, K.A., Davis, J.S., McNeil, Y.R., Chen, Y., Volkheimer, A.D., Weinberg, J.B., Anstey, N.M. and Woodberry, T. (2014) Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit. Care 18, R163
26. + population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204, 1463-1474
27. Brudecki, L., Ferguson, D.A., McCall, C.E. and El Gazzar, M. (2012) Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect. Immun. 80, 2026-2034
28. Sander, L.E., Sackett, S.D., Dierssen, U., Beraza, N., Linke, R.P., Muller, M., Blander, J.M., Tacke, F. and Trautwein, C. (2010) Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453-1464
29. Institute of Laboratory Animal Resources (U.S.), Committee on Care and Use of Laboratory Animals. and National Institutes of Health (U.S.), Division of Research Resources. (1985) Guide for the Care and Use of Laboratory Animals, Rev. edn, U.S. Department of Health and Human Services, Public Health Service, National Insititutes of Health, Bethesda, MD
30. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63
31. Loveland, B.E., Johns, T.G., Mackay, I.R., Vaillant, F., Wang, Z.X. and Hertzog, P.J. (1992) Validation of the MTT dye assay for enumeration of cells in proliferative and antiproliferative assays. Biochem. Int. 27, 501-510
32. Beauvillain, C., Cunin, P., Doni, A., Scotet, M., Jaillon, S., Loiry, M.L., Magistrelli, G., Masternak, K., Chevailler, A., Delneste, Y. et al. (2011) CCR7 is involved in the migration of neutrophils to lymph nodes. Blood 117, 1196-1204
33. Forster, R., Davalos-Misslitz, A.C. and Rot, A. (2008) CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8, 362-371
34. Ostrand-Rosenberg, S. and Sinha, P. (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182, 4499-4506
35. Youn, J.I., Nagaraj, S., Collazo, M. and Gabrilovich, D.I. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791-5802
36. Boiko, J.R. and Borghesi, L. (2013) Hematopoiesis sculpted by pathogens: toll-like receptors and inflammatory mediators directly activate stem cells. Cytokine 57, 1-8
37. Opal, S.M., Scannon, P.J., Vincent, J.L., White, M., Carroll, S.F., Palardy, J.E., Parejo, N.A., Pribble, J.P. and Lemke, J.H. (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J. Infect. Dis. 180, 1584-1589
38. Hotchkiss, R.S., Coopersmith, C.M., McDunn, J.E. and Ferguson, T.A. (2009) The sepsis seesaw: tilting toward immunosuppression. Nat. Med. 15, 496-497
39. Hotchkiss, R.S., Tinsley, K.W., Swanson, P.E., Schmieg, Jr, R.E., Hui, J.J., Chang, K.C., Osborne, D.F., Freeman, B.D., Cobb, J.P., Buchman, T.G. et al. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166, 6952-6963
40. Opdenakker, G., Fibbe, W.E. and Van Damme, J. (1998) The molecular basis of leukocytosis. Immunol. Today 19, 182-189
41. Wang, S.Y., Su, C.Y., Hsu, M.L., Chen, L.Y., Tzeng, C.H. and Ho, C.K. (1991) Effect of lipopolysaccharide on the production of colony-stimulating factors by the stromal cells in long-term bone marrow culture. Exp. Hematol. 19, 122-127
42. He, N., Zhang, L., Cui, J. and Li, Z. (2014) Bone marrow vascular niche: home for hematopoietic stem cells. Bone Marrow Res. 2014, 128436
43. Villablanca, E.J., Raccosta, L., Zhou, D., Fontana, R., Maggioni, D., Negro, A., Sanvito, F., Ponzoni, M., Valentinis, B., Bregni, M. et al. (2010) Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat. Med. 16, 98-105
44. Cunningham, H.D., Shannon, L.A., Calloway, P.A., Fassold, B.C., Dunwiddie, I., Vielhauer, G., Zhang, M. and Vines, C.M. (2010) Expression of the C-C chemokine receptor 7 mediates metastasis of breast cancer to the lymph nodes in mice. Transl. Oncol. 3, 354-361
45. Nagaraj, S. and Gabrilovich, D.I. (2008) Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res. 68, 2561-2563
46. Nagaraj, S., Youn, J.I. and Gabrilovich, D.I. (2013) Reciprocal relationship between myeloid-derived suppressor cells and T cells. J. Immunol. 191, 17-23
47. Liu, X., Miller, M.J., Joshi, M.S., Sadowska-Krowicka, H., Clark, D.A. and Lancaster, Jr, J.R. (1998) Diffusion-limited reaction of free nitric oxide with erythrocytes. J. Biol. Chem. 273, 18709-18713
48. Ford, P.C., Wink, D.A. and Stanbury, D.M. (1993) Autoxidation kinetics of aqueous nitric oxide. FEBS Lett. 326, 1-3
49. Bogdan, C. (2011) Regulation of lymphocytes by nitric oxide. Methods Mol. Biol. 677, 375-393
50. Nagai, Y., Garrett, K.P., Ohta, S., Bahrun, U., Kouro, T., Akira, S., Takatsu, K. and Kincade, P.W. (2006) Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24, 801-812
51. Esplin, B.L., Shimazu, T., Welner, R.S., Garrett, K.P., Nie, L., Zhang, Q., Humphrey, M.B., Yang, Q., Borghesi, L.A. and Kincade, P.W. (2011) Chronic exposure to a TLR ligand injures hematopoietic stem cells. J. Immunol. 186, 5367-5375
52. Greifenberg, V., Ribechini, E., Rossner, S. and Lutz, M.B. (2009) Myeloid-derived supp essor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 39, 2865-2876
53. Highfill, S.L., Rodriguez, P.C., Zhou, Q., Goetz, C.A., Koehn, B.H., Veenstra, R., Taylor, P.A., Panoskaltsis-Mortari, A., Serody, J.S., Munn, D.H. et al. (2010) Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116, 5738-5747
54. Arora, M., Poe, S.L., Oriss, T.B., Krishnamoorthy, N., Yarlagadda, M., Wenzel, S.E., Billiar, T.R., Ray, A. and Ray, P. (2010) TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratorymyeloid cells suppress Th2 effector function in the lung. Mucosal Immunol. 3, 578-593